P2-5-21Phase II study of Ccr-based dose-control of S-1 in 1st line SOX + bevacizumab regimen for advanced colorectal cancer
2015
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI